11X Stock Market Accelerator Summit

Eric Fry reveals how an A.I.-based secret could make you up to 11 times RICHER on the same stocks you’re investing in now… without using options, leverage, or anything risky.

Wed, September 27 at 8:00PM ET

Why Is Marker Therapeutics (MRKR) Stock Up 27% Today?


  • Marker Therapeutics (MRKR) stock is gaining with pre-clinical study results.
  • The company saw positive in vitro performance against a lymphoma cell line.
  • This has MRKR shares experiencing heavy trading today.
MRKR Stock - Why Is Marker Therapeutics (MRKR) Stock Up 27% Today?

Source: Shutterstock

Marker Therapeutics (NASDAQ:MRKR) stock is rising higher on Wednesday as investors react to positive pre-clinical news from the clinical-stage immuno-oncology company.

Today’s results come from a test of MT-601 in lymphoma cells. MT-601 is the company’s “multiple tumor-associated antigens (multiTAA)-specific T cell product candidate.” Encouraged by positive data from other treatments, Marker Therapeutics sought to determine the effectiveness of MT-601 in lymphoma cells.

This saw Marker assessing the ability of MT-601 to kill in vitro in a lymphoma cell line. The company’s results from this test show that it was effective at killing lymphoma cells “regardless of their CD19 expression levels.”

Juan Vera, President and CEO of Marker Therapeutics, said the following about the results:

“These pre-clinical findings reinforce previous TACTAL clinical observations, highlighting the potential benefit of our innovative multiTAA-specific T cell therapy in CD19 CAR T refractory lymphoma patients. Our Investigational New Drug (IND) application for MT-601 for the treatment of patients with relapsed non-Hodgkin lymphoma has been cleared by the FDA and we are excited to further explore the potential benefits of MT-601 in our multicenter Phase 1 clinical trial, which was initiated in the first quarter of 2023.”

MRKR Stock Movement Today

With this positive news comes heavy trading of MRKR stock. As of this writing, more than 32 million shares have been traded. That’s a massive surge in trading volume compared to its daily average of 142,000 shares.

MRKR stock is up 27.3% as of Wednesday morning.

Investors can find even more of the most recent stock market news below!

We’ve got highlights of all the most important stock market stories worth reading about today. A few examples include why shares of Bowlero (NYSE:BOWL), Palantir (NYSE:PLTR) and TOP Financial Group (NASDAQ:TOP) are in the news today. You can catch up on all of this news with the following links!

More Stock Market News for Wednesday

On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.

Read More:Penny Stocks — How to Profit Without Getting Scammed

On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

Article printed from InvestorPlace Media, https://investorplace.com/2023/05/why-is-marker-therapeutics-mrkr-stock-up-27-today/.

©2023 InvestorPlace Media, LLC